Trillium Therapeutics Inc. logo
Trillium Therapeutics Inc. TRIL
$ 18.44 0.0%

Trillium Therapeutics Inc. Income Statement 2011-2024 | TRIL

Annual Income Statement Trillium Therapeutics Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.1 B 104 M 24.3 M 79.1 M 36.8 M 53.4 M 58.4 M 20.5 M - -

Shares

83.8 M 25.3 M 13.9 M 9.77 M 7.82 M 6.64 M 4.2 M 1.36 M - -

Net Income

-59.3 M -41.6 M -32.9 M -45.1 M -31.7 M -14.7 M -12.9 M -4.03 M -1.07 M -3.11 M

Revenue

148 K 124 K - - - - - - - -

EBITDA

-60.9 M -33.3 M -33.9 M -37.5 M -30.5 M -20.9 M -12.5 M -3.39 M -1.09 M -2.88 M

Operating Expenses

61.6 M 32.6 M 34.5 M 32.6 M 25.1 M 15.3 M 11.3 M - - -

General and Administrative Expenses

36.3 M 4.3 M 3.85 M 3.85 M 3.57 M 2.64 M 2.34 M 904 K 469 K 1.41 M

All numbers in USD currency